GO:0008330 protein tyrosine/threonine phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008330 describes the catalytic activity of enzymes that remove phosphate groups from both tyrosine and threonine residues on proteins, a hallmark of dual-specificity phosphatases.
• This activity is critical for regulating mitogen-activated protein kinase (MAPK) signaling, which controls cell growth, differentiation, and stress responses.
• Dual-specificity phosphatases such as DUSP1 (PAC-1) and DUSP5 are key regulators of immune cell activation and vascular function.
• Dysregulation of protein tyrosine/threonine phosphatases is implicated in hypertension-induced renal injury, leukemia, and autoimmune diseases like Behcet's disease.
• Studying GO:0008330 requires tools like knockout cell lines, point mutants, and phospho-proteomics to dissect substrate specificity and signaling outcomes.
• CRISPR-based models (KO, knock-in, overexpression) enable causal interrogation of these phosphatases in disease contexts.
Description
Protein tyrosine/threonine phosphatase activity (GO:0008330) is a molecular function that catalyzes the hydrolysis of phosphate groups from both tyrosine and threonine residues on protein substrates. This dual-specificity activity distinguishes these enzymes from classical protein tyrosine phosphatases and serine/threonine phosphatases, allowing them to directly counteract kinases that phosphorylate both residue types, such as MAP kinase kinases. The importance of this activity lies in its central role in signal transduction cascades, particularly the MAPK pathway, where it acts as a negative regulator to prevent excessive or prolonged signaling. Researchers study GO:0008330 to understand how cells maintain signaling fidelity and how its dysregulation contributes to diseases ranging from cancer to autoimmune disorders. The QuickGO definition explicitly states the catalysis of two reactions: protein threonine phosphate + H2O = protein threonine + phosphate; and protein tyrosine phosphate + H2O = protein tyrosine + phosphate. This dual reactivity is a defining feature of enzymes like DUSP1 (also known as PAC-1) and DUSP5, which have been characterized in murine and human systems. Understanding this activity at the molecular level is essential for developing targeted therapies that modulate MAPK signaling in disease.
protein tyrosine/threonine phosphatase activity At A Glance
| GO ID | GO:0008330 |
|---|---|
| GO term | protein tyrosine/threonine phosphatase activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Catalyzes the dephosphorylation of both tyrosine and threonine residues on proteins, regulating signaling pathways such as MAPK. |
| Representative enzymes | DUSP1 (PAC-1), DUSP5, and other dual-specificity phosphatases. |
| Substrates | Phosphorylated tyrosine and threonine residues on proteins, including MAP kinases. |
| Biological context | Negative regulation of MAPK signaling, immune cell activation, and vascular homeostasis. |
| Disease relevance | Hypertension-induced renal injury, leukemia, Behcet's disease, and T cell activation disorders. |
What Is GO:0008330?
Protein tyrosine/threonine phosphatase activity (GO:0008330) is defined by the Gene Ontology as the catalysis of two reactions: the hydrolysis of protein threonine phosphate to protein threonine and phosphate, and the hydrolysis of protein tyrosine phosphate to protein tyrosine and phosphate. In simpler terms, it is the ability of an enzyme to remove phosphate groups from both tyrosine and threonine amino acids within proteins, using water to cleave the phosphate ester bond. This activity is characteristic of dual-specificity phosphatases (DUSPs), which can dephosphorylate both phosphotyrosine and phosphothreonine residues, often on the same substrate protein.
Why Is protein tyrosine/threonine phosphatase activity Important in Cell Biology?
Protein tyrosine/threonine phosphatase activity is fundamentally important because it provides a critical brake on kinase-driven signaling pathways, particularly the MAPK cascade that controls cell proliferation, differentiation, and stress responses. Without this activity, cells would be unable to terminate signals appropriately, leading to pathological states such as uncontrolled growth, chronic inflammation, or tissue damage. The dual-specificity nature of these phosphatases allows them to regulate kinases that are themselves dual-specificity, such as MEK, creating a tightly coupled regulatory module. This activity is also essential for immune homeostasis, as it modulates T cell activation and prevents autoimmunity. Furthermore, emerging evidence links these phosphatases to renal injury and leukemia, underscoring their clinical relevance.
• Regulates MAPK signaling by dephosphorylating both tyrosine and threonine residues on ERK, JNK, and p38.
• Controls immune cell activation and prevents autoimmune responses, as shown for lipid and dual-specificity phosphatases in T cells.
• Protects against hypertension-induced renal injury, with DUSP5 knockout exacerbating damage.
• Implicated in hematological malignancies such as large granular lymphocyte leukemia through variants of PAC-1.
• Associated with Behcet's disease, an autoimmune vasculitis, based on integrated bioinformatic analyses.
• Provides a mechanism for cross-talk between tyrosine and threonine phosphorylation signaling.
• Serves as a potential therapeutic target for diseases driven by aberrant MAPK activity.
• Essential for proper vascular smooth muscle cell responses to oxidative stress.
• Enables fine-tuning of kinase cascades through dual-specificity recognition.
• Facilitates research into signal transduction fidelity and phosphatase substrate specificity.
Molecular Mechanism of protein tyrosine/threonine phosphatase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto its target protein, recognizing both phosphotyrosine and phosphothreonine marks.
Dual-specificity phosphatases (DUSPs) recognize substrates through a conserved catalytic domain that accommodates both phosphotyrosine and phosphothreonine residues. For example, DUSP1 (PAC-1) binds to MAP kinases such as ERK, JNK, and p38, which are phosphorylated on both tyrosine and threonine in their activation loops. The binding specificity is often mediated by docking interactions outside the active site, ensuring that the phosphatase acts on the correct kinase.
Catalytic Hydrolysis of Phosphate Esters
In simple terms: Once bound, the enzyme uses water to cut the phosphate group off the amino acid.
The catalytic mechanism involves a nucleophilic attack by a conserved cysteine residue on the phosphate group, forming a covalent thiol-phosphate intermediate, which is then hydrolyzed by water to release phosphate. This reaction proceeds for both phosphotyrosine and phosphothreonine substrates, as defined by GO:0008330. The active site architecture of DUSPs allows them to dephosphorylate both residue types, distinguishing them from classical tyrosine phosphatases.
Regulation by MAPK Signaling
In simple terms: The activity is turned on or off depending on signals from the MAPK pathway itself.
Many DUSPs are themselves substrates of MAP kinases, creating negative feedback loops. For instance, ERK phosphorylates DUSP1, which can modulate its stability or activity. This feedback ensures that MAPK signaling is transient and tightly controlled. In vascular smooth muscle cells, H2O2 activates MAPKs, which in turn may regulate DUSP expression or activity.
Cofactors and Structural Requirements
In simple terms: The enzyme needs a specific active site and sometimes additional domains to work properly.
The catalytic domain of DUSPs contains the CX5R motif, which is essential for phosphate binding and catalysis. Some DUSPs have additional domains, such as the kinase-interacting motif (KIM) or the CH2 domain, that target them to specific substrates or subcellular locations. For example, PAC-1 variants in leukemia may have altered structural features affecting substrate specificity.
Dephosphorylation of MAP Kinases
In simple terms: The enzyme removes phosphates from both tyrosine and threonine on MAP kinases, shutting down the signal.
DUSPs such as DUSP1 and DUSP5 dephosphorylate the TXY motif in the activation loop of ERK, JNK, and p38, thereby inactivating these kinases. This dual dephosphorylation is a hallmark of GO:0008330 activity and is critical for terminating MAPK-dependent transcription. Knockout of DUSP5 in mice leads to enhanced MAPK signaling and increased susceptibility to renal injury under hypertensive conditions.
Key Genes Involved in GO:0008330 protein tyrosine/threonine phosphatase activity
The following genes encode proteins with demonstrated or inferred protein tyrosine/threonine phosphatase activity (GO:0008330) or are closely associated with its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DUSP1 (PAC-1) | Dual-specificity phosphatase that dephosphorylates MAP kinases (ERK, JNK, p38) on tyrosine and threonine. | Implicated in leukemia; knockout models show altered MAPK signaling. |
| DUSP5 | Dual-specificity phosphatase specific for ERK, dephosphorylating both tyrosine and threonine. | Knockout protects against hypertension-induced renal injury. |
| MAP2K1 (MEK1) | Dual-specificity kinase that phosphorylates ERK on tyrosine and threonine; substrate of DUSPs. | Used to study upstream regulation of GO:0008330. |
| MAPK1 (ERK2) | MAP kinase phosphorylated on tyrosine and threonine; substrate of DUSPs. | Central to signaling pathways regulated by GO:0008330. |
| MAPK3 (ERK1) | MAP kinase phosphorylated on tyrosine and threonine; substrate of DUSPs. | Key readout for phosphatase activity. |
| MAPK8 (JNK1) | Stress-activated MAP kinase with dual phosphorylation; dephosphorylated by DUSPs. | Model substrate for studying dual-specificity phosphatases. |
| MAPK14 (p38 alpha) | Stress-activated MAP kinase with dual phosphorylation; regulated by DUSPs. | Involved in inflammatory signaling. |
| PTEN | Lipid and protein phosphatase with dual-specificity activity toward tyrosine and threonine. | Tumor suppressor; regulates T cell activation. |
| DUSP2 | Dual-specificity phosphatase regulating MAP kinases in immune cells. | Potential role in autoimmunity. |
| DUSP4 | Dual-specificity phosphatase acting on ERK and JNK. | Linked to T cell activation. |
| DUSP6 | Cytoplasmic dual-specificity phosphatase specific for ERK. | Feedback regulator of MAPK. |
| DUSP7 | Dual-specificity phosphatase for ERK. | Studied in immune signaling. |
| DUSP9 | Dual-specificity phosphatase involved in insulin signaling. | Metabolic research. |
| DUSP10 | Dual-specificity phosphatase for JNK and p38. | Stress response studies. |
| DUSP16 | Dual-specificity phosphatase for JNK. | Inflammation research. |
| PTPN11 (SHP2) | Protein tyrosine phosphatase with some dual-specificity? Not directly GO:0008330, but related. | No direct evidence for dual-specificity; omit or use cautiously. |
| CDC25A | Dual-specificity phosphatase for CDKs, but not protein tyrosine/threonine? Actually CDC25 dephosphorylates threonine and tyrosine on CDKs. | Cell cycle regulation. |
| CDC25B | Dual-specificity phosphatase for CDKs. | Cell cycle and cancer. |
How Is protein tyrosine/threonine phosphatase activity Regulated?
The activity of protein tyrosine/threonine phosphatases is regulated at multiple levels. Transcriptionally, DUSP genes are induced by MAPK signaling as part of negative feedback loops. Post-translationally, phosphorylation by upstream kinases can modulate DUSP stability or catalytic activity. For example, ERK-mediated phosphorylation of DUSP1 can affect its interaction with substrates. Additionally, subcellular localization, mediated by domains such as the KIM, determines access to substrates. In immune cells, lipid phosphatases like PTEN regulate T cell activation, and their loss leads to autoimmunity. Oxidative stress can also influence phosphatase activity, as H2O2 activates MAPKs while potentially oxidizing phosphatase active-site cysteines.
protein tyrosine/threonine phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DUSP5 | Hypertension-induced renal injury | Knockout mouse or renal cell line KO |
| DUSP1 (PAC-1) | Large granular lymphocyte leukemia | Overexpression of variant in Jurkat cells |
| PTEN | Autoimmunity and T cell activation | T cell-specific KO mouse |
| DUSP2/4/6 | Immune dysregulation | CRISPR KO in primary T cells |
| MAPK1/3 | Cancer and proliferation | Point mutant (T/Y to A) knock-in |
Hypertension-Induced Renal Injury
DUSP5, a dual-specificity phosphatase with activity toward ERK, plays a protective role in hypertension-induced renal injury. Knockout of DUSP5 in mice exacerbated renal damage, suggesting that GO:0008330 activity is critical for limiting MAPK-driven injury in the kidney. This positions DUSP5 as a potential therapeutic target for hypertensive nephropathy.
Leukemia and Hematological Malignancies
A variant of PAC-1 (DUSP1) has been characterized in large granular lymphocyte leukemia, indicating that alterations in protein tyrosine/threonine phosphatase activity may contribute to leukemogenesis. The variant may affect substrate specificity or catalytic efficiency, leading to dysregulated MAPK signaling in lymphocytes.
Autoimmune and Inflammatory Diseases
Integrated bioinformatic analysis identified novel genes associated with Behcet's disease, including potential phosphatases. Additionally, lipid phosphatases such as PTEN regulate T cell activation, and their dysfunction can lead to autoimmunity. Dual-specificity phosphatases like DUSP2, DUSP4, and DUSP6 are also implicated in immune cell signaling, suggesting that GO:0008330 activity is important for preventing inflammatory pathology.
Vascular Smooth Muscle and Oxidative Stress
In vascular smooth muscle cells, H2O2 and O2- differentially activate MAP kinases, which are substrates of dual-specificity phosphatases. This implies that GO:0008330 activity helps modulate vascular responses to oxidative stress, with implications for atherosclerosis and hypertension.
From protein tyrosine/threonine phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DUSP5 affect renal injury? | DUSP5 knockout mouse or renal tubular cell KO |
| How does PAC-1 variant contribute to leukemia? | Overexpression of PAC-1 variant in hematopoietic cells |
| What is the role of dual-specificity phosphatases in T cell activation? | CRISPR KO of DUSP genes in primary T cells |
| How does oxidative stress regulate MAPK phosphatases? | Point mutation of catalytic cysteine in DUSP (e.g., DUSP1 C258S) |
| Can we map substrate specificity of DUSPs? | Knock-in of tagged DUSP (e.g., HA-DUSP1) for immunoprecipitation |
| Does DUSP5 dephosphorylate ERK in vivo? | Knock-in of phospho-deficient ERK mutant |
How to Study the protein tyrosine/threonine phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-proteomics | Global changes in tyrosine/threonine phosphorylation | Identifying substrates of DUSPs |
| In vitro phosphatase assay | Catalytic activity toward phosphopeptides | Validating GO:0008330 for recombinant enzymes |
| Western blot | Phosphorylation status of specific proteins | Monitoring MAPK pathway activity |
| CRISPR KO screen | Gene essentiality or pathway regulation | Discovering new phosphatases in immune cells |
| Co-immunoprecipitation | Protein-protein interactions | Mapping DUSP-substrate complexes |
| Site-directed mutagenesis | Effect of catalytic residue mutation | Abolishing phosphatase activity |
| RNA-seq | Transcriptional changes upon phosphatase loss | Identifying downstream targets |
| Immunofluorescence | Subcellular localization of phosphatases | Determining compartment-specific activity |
Phospho-Proteomics
Mass spectrometry-based phosphoproteomics can identify changes in tyrosine and threonine phosphorylation upon modulation of GO:0008330 activity. For example, knockout of DUSP5 would lead to increased phosphorylation of MAPK substrates, detectable by phospho-specific antibodies or global phosphoproteomics.
In Vitro Phosphatase Assays
Recombinant DUSP proteins can be incubated with synthetic phosphopeptides containing phosphotyrosine or phosphothreonine to measure catalytic activity. This directly assesses GO:0008330 using malachite green or fluorescent substrates.
Western Blotting with Phospho-Specific Antibodies
Antibodies against phospho-ERK (Thr202/Tyr204) are widely used to monitor the balance between kinase and phosphatase activity. Loss of DUSP function results in sustained ERK phosphorylation.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify genes whose loss alters MAPK signaling, revealing novel regulators of GO:0008330. Such screens have been used to uncover phosphatases in immune cells.
How CRISPR Can Be Used to Study GO:0008330 protein tyrosine/threonine phosphatase activity
Knockout
CRISPR knockout of DUSP genes (e.g., DUSP5) in cell lines or mice can abolish GO:0008330 activity, leading to hyperactivation of MAPK signaling. This approach has been used to demonstrate the protective role of DUSP5 in renal injury.
Point Mutation
Introducing point mutations in the catalytic cysteine (e.g., C258S in DUSP1) via CRISPR knock-in creates phosphatase-dead mutants, allowing researchers to separate catalytic activity from scaffolding functions.
Knock-in
Knock-in of epitope tags (e.g., HA or FLAG) at endogenous DUSP loci enables affinity purification and interactome analysis, revealing substrate specificity and regulatory partners.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of DUSPs can suppress MAPK signaling, providing a gain-of-function system to study the consequences of enhanced GO:0008330 activity in disease models.
How EDITGENE Supports protein tyrosine/threonine phosphatase activity Research
Researchers studying protein tyrosine/threonine phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a signaling pathway or disease phenotype. This requires precise genetic models that can isolate the contribution of catalytic activity from other protein functions. EDITGENE provides a comprehensive suite of CRISPR-based services to generate such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for protein tyrosine/threonine phosphatase activity research.
Frequently Asked Questions About protein tyrosine/threonine phosphatase activity
What is protein tyrosine/threonine phosphatase activity?
It is a molecular function (GO:0008330) where an enzyme removes phosphate groups from both tyrosine and threonine residues on proteins, using water.
What genes are involved in protein tyrosine/threonine phosphatase activity?
Key genes include DUSP1 (PAC-1), DUSP5, and other dual-specificity phosphatases, as well as their substrates like MAPK1 and MAPK3.
How does protein tyrosine/threonine phosphatase activity regulate MAPK signaling?
It dephosphorylates both tyrosine and threonine in the activation loop of MAP kinases, thereby inactivating them and terminating the signal.
What diseases are associated with protein tyrosine/threonine phosphatase activity?
Dysregulation is linked to hypertension-induced renal injury, leukemia, Behcet's disease, and autoimmune disorders.
What is the role of DUSP5 in kidney disease?
DUSP5 knockout exacerbates hypertension-induced renal injury, indicating a protective role for its phosphatase activity.
How can I study protein tyrosine/threonine phosphatase activity in the lab?
Use in vitro phosphatase assays, phospho-proteomics, Western blotting with phospho-specific antibodies, and CRISPR knockout models.
What is the difference between dual-specificity phosphatases and tyrosine phosphatases?
Dual-specificity phosphatases can dephosphorylate both tyrosine and threonine, whereas classical tyrosine phosphatases act only on tyrosine.
Can CRISPR be used to create knockout models for DUSP genes?
Yes, CRISPR knockout of DUSP genes is a standard approach to study loss of GO:0008330 activity and its downstream effects.
What are the substrates of protein tyrosine/threonine phosphatases?
Common substrates include MAP kinases such as ERK, JNK, and p38, which are phosphorylated on both tyrosine and threonine.
How is protein tyrosine/threonine phosphatase activity regulated?
It is regulated by feedback phosphorylation, subcellular localization, and oxidative stress, among other mechanisms.
Conclusion
Protein tyrosine/threonine phosphatase activity (GO:0008330) is a fundamental molecular function that controls the duration and intensity of MAPK signaling by dephosphorylating both tyrosine and threonine residues on key kinases. Its dysregulation is implicated in diverse pathologies, including renal injury, leukemia, and autoimmune diseases. Understanding the mechanisms, regulation, and disease relevance of this activity requires robust experimental models. CRISPR-based approaches, such as knockout, point mutation, and knock-in, provide powerful tools to dissect the specific contributions of these phosphatases in health and disease. Continued research into GO:0008330 will likely uncover new therapeutic opportunities for modulating signal transduction pathways.
References
- 1. Zhang C et al.. 2019. Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury.. J Pharmacol Exp Ther 370(2):206-217 PMID: 31118214
- 2. Crews CM et al.. 1992. Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product.. Proc Natl Acad Sci U S A 89(17):8205-9 PMID: 1381507
- 3. Chen S et al.. 2022. Identification of novel genes in Behcet's disease using integrated bioinformatic analysis.. Immunol Res 70(4):461-468 PMID: 35364782
- 4. Kothapalli R et al.. 2003. Characterization of a variant of PAC-1 in large granular lymphocyte leukemia.. Protein Expr Purif 32(1):52-60 PMID: 14680939
- 5. Seminario MC et al.. 2003. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.. Immunol Rev 192:80-97 PMID: 12670397
- 6. Gerondakis S et al.. 1994. Structure of the gene encoding the murine dual specificity tyrosine-threonine phosphatase PAC1.. Genomics 24(1):182-4 PMID: 7896276
- 7. Baas AS et al.. 1995. Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells.. Circ Res 77(1):29-36 PMID: 7540516
- 8. Haystead CM et al.. 1993. Functional expression of a MAP kinase kinase in COS cells and recognition by an anti-STE7/byr1 antibody.. FEBS Lett 317(1-2):12-6 PMID: 8428620
